Loyal

Other Pharmaceuticals and BiotechnologyWebsite
Current Valuation
$430.0M
As of October 11, 2024
Total Funding Raised
$136.5M
Across 2 rounds
Last Round
Later Stage VC

$22.2M

Last Funding
Oct 2024

Funding date

Capital Efficiency
3.15x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
N/AUnknownUndisclosedN/A-
September 23, 2021Early Stage VC (Series A)$27.7MN/A-
Valuation Analysis

Current Valuation Metrics

Loyal is currently valued at $430.0M as of October 11, 2024. The company has raised a total of $136.5M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 3.15x, Loyal has achieved a valuation that is 3.15 times the total capital raised.

Track Loyal Valuation Updates

Get notified when Loyal raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Loyal's valuation history, funding rounds, and growth metrics.

No credit card required

What is Loyal Worth in 2026?

Loyal is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Loyal's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Loyal Valuation is Determined

Private company valuations like Loyal's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.